author-photo

Nadine Tung

Beth Israel Deaconess Medical Center
Harvard University
Beth Israel Deaconess Hospital

297

Papers

16284

Citations

Citation Trend

Filter By

Papers (297) Sort By

JournalConferenceOthers

Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).

2021 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (1)
Abstract PD3-10: Patient perspectives on chemotherapy de-escalation: “Don’t de-escalate! I don’t want to die!”

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Weight Gain and the Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers.

2021 Cancer Epidemiology, Biomarkers & Prevention
Show All
- Source
- Cite
- Save
Citations (0)
Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer.

2021 Future Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Survival from breast cancer in women with a BRCA2 mutation by treatment

2021 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (2)
Evaluation of TP53 Variants Detected on Peripheral Blood or Saliva Testing: Discerning Germline From Somatic TP53 Variants

2021
Show All
- Source
- Cite
- Save
Citations (0)
A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast cancer.

2021 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (0)
Adjuvant PARP Inhibitors in Patients With High-Risk Early-Stage HER2-Negative Breast Cancer and Germline BRCA Mutations: ASCO Hereditary Breast Cancer Guideline Rapid Recommendation Update

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Patient perspectives on chemotherapy de-escalation in breast cancer.

2021 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Twenty-one-gene recurrence score (RS) in germline (g)CHEK2 mutation-associated versus sporadic breast cancers (BC): A multi-site case-control study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号